← Back to Search

IORT for Pancreatic Cancer (PACER Trial)

N/A

Recruiting

Led By Theodore S. Hong, MD

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 years

Awards & highlights

PACER Trial Summary

This trial is testing a new possible treatment for pancreatic cancer.

Eligible Conditions

Pancreatic Cancer

PACER Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

2 Year Overall Survival

Secondary outcome measures

Adverse events associated with IORT

Local Control

Median Progression Free Survival

PACER Trial Design

1Treatment groups

Experimental Treatment

Group I: IORTExperimental Treatment1 Intervention

IORT will be administered as determined to be best practice by the treating radiation oncologist, Electron beam intraoperative radiation therapy will occur in a hybrid operating room with a portable linear accelerator

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

IntraOp/MobetronUNKNOWN

Massachusetts General HospitalLead Sponsor

2,928 Previous Clinical Trials

13,198,155 Total Patients Enrolled

Theodore S. Hong, MDPrincipal InvestigatorMassachusetts General Hospital

10 Previous Clinical Trials

575 Total Patients Enrolled

Media Library

IORT Clinical Trial Eligibility Overview. Trial Name: NCT03716531 — N/A

Pancreatic Cancer Research Study Groups: IORT

Pancreatic Cancer Clinical Trial 2023: IORT Highlights & Side Effects. Trial Name: NCT03716531 — N/A

IORT 2023 Treatment Timeline for Medical Study. Trial Name: NCT03716531 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current capacity for participants in this medical experiment?

"This medical trial is seeking two hundred eligible participants from various sites, including the University of California in Irvine and Mayo Clinic's Jacksonville facility."

Answered by AI

How many health institutions are currently conducting this experiment?

"Currently, 6 medical sites are engaged in this trial which span Irvine, Jacksonville and Boston. Participants can select the closest centre to them to minimize travelling demands when they join the study."

Answered by AI

Are there any vacant opportunities in this medical experiment for participants?

"Affirmative. According to clinicaltrials.gov, this medical study is actively looking for participants since it was first posted on March 19th 2019 and its most recent update occurred on September 7th 2022. To date, they are still trying to enroll 200 patients across 6 different locations."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Electron Beam Intraoperative Radiation Therapy Following Chemoradiation in Patients With Pancreatic Cancer With Vascular Involvement

Theodore Sunki Hong 2019. "Electron Beam Intraoperative Radiation Therapy Following Chemoradiation in Patients With Pancreatic Cancer With Vascular Involvement". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03716531.